Trade Mark Journal No.2026/009 27 February 2026
WO0000001901284 (1,42)
Office of origin: United States of America
Date of International Registration:24 December 2025
Date of designation in the UK:
24 December 2025

BIOLOGY
International priority date claimed: 10 July 2025
(United States of America)
(99276246)
- Class 1
- Enzymes for drug discovery for scientific and research purposes; enzymes for pharmaceutical and therapeutic research and scientific development purposes.
- Class 42
- Laboratory research and medical contract research services relating to molecular sciences; drug discovery services; pharmaceutical research and development; therapeutic product research and development services; providing information regarding drug discovery, pharmaceuticals research and development, and therapeutics product research and development.
Reaction Biology Corporation
Representative: Jessica L. Rothstein GOODWIN PROCTER LLP, 620 Eighth Avenue, New York NY 10018, UNITED STATES OF AMERICA